Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk
Completed
- Conditions
- Cardiovascular DiseasesCardiovascular Risk Factor
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- SomaLogic, Inc.
- Target Recruit Count
- 244
- Registration Number
- NCT03599531
- Locations
- 🇺🇸
Boulder Heart, Boulder, Colorado, United States
Protandim and the Metabolic Syndrome
Not Applicable
Withdrawn
- Conditions
- Metabolic Syndrome
- First Posted Date
- 2010-05-18
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- SomaLogic, Inc.
- Registration Number
- NCT01125501
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
News
No news found